Skip to main content
Fig. 5 | Cell Division

Fig. 5

From: Cilostazol protects against degenerative cervical myelopathy injury and cell pyroptosis via TXNIP-NLRP3 pathway

Fig. 5

Effects of Cilostazol on cleaved-Caspase-1, TXNIP and NLRP3 expressions in DCM rats (Scar bar: 20 μm). A TXNIP expression was detected by immunohistochemistry; B Western blot images; C cleaved-Caspase-1 expressions; D TXNIP expressions; E NLRP3 expressions. *p < 0.05 vs. Sham group; #p < 0.05 vs. DCM group; &p < 0.05 vs. Cilostazol (15 mg/kg) group

Back to article page